Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Controlling Hypertension Outcomes by Improved Communication & Engagement
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated:  3/15/2016
166
mi
from 43215
Indianapolis, IN
Controlling Hypertension Outcomes by Improved Communication & Engagement
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated: 3/15/2016
Richard Roudebush VA Medical Center, Indianapolis
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Controlling Hypertension Outcomes by Improved Communication & Engagement
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated:  3/15/2016
166
mi
from 43215
Indianapolis, IN
Controlling Hypertension Outcomes by Improved Communication & Engagement
Controlling Hypertension Outcomes by Improved Communication & Engagement (CHOICE)
Status: Enrolling
Updated: 3/15/2016
Richard Roudebush VA Medical Center
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated:  3/16/2016
643
mi
from 43215
Boston, MA
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Beth Israel Deaconess Medical Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated:  3/16/2016
643
mi
from 43215
Boston, MA
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated:  3/16/2016
607
mi
from 43215
Worcester, MA
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
University of Massachusetts
607
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated:  3/16/2016
4495
mi
from 43215
Salzburg,
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical ICU Patients
Status: Enrolling
Updated: 3/16/2016
University of Salzburg
4495
mi
from 43215
Salzburg,
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
795
mi
from 43215
Orlando, FL
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Compass Research LLC
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
643
mi
from 43215
Boston, MA
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Beth Israel Deaconess
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
513
mi
from 43215
Albany, NY
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Neurosciences Institute, Albany Medical College
513
mi
from 43215
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
480
mi
from 43215
New York, NY
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Mount Sinai Hospital
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
849
mi
from 43215
Oklahoma City, OK
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
University of Oklahoma Harold Hamm Diabetes Center
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
991
mi
from 43215
Houston, TX
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Houston Neurocare
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
1511
mi
from 43215
Salt Lake City, UT
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
University of Utah
1511
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
423
mi
from 43215
Norfolk, VA
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
East Virginia Medical School Strelitz Diabetes Center
423
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
2083
mi
from 43215
Walnut creek, CA
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Diablo Clinical Research Inc
2083
mi
from 43215
Walnut creek, CA
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
922
mi
from 43215
Palm Beach Gardens, FL
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Palm Beach Neurological Center,
922
mi
from 43215
Palm Beach Gardens, FL
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
274
mi
from 43215
Chicago, IL
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
995
mi
from 43215
Houston, TX
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Methodist Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
2001
mi
from 43215
Seattle, WA
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Rainier Clinical Research
2001
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  3/16/2016
6752
mi
from 43215
Seongnam,
Safety and Efficacy Study for the Treatment of Painful Diabetic Neuropathy
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 3/16/2016
Seoul National University Bundang Hospital
6752
mi
from 43215
Seongnam,
Click here to add this to my saved trials
Effects of Frailty, Sarcopenia and Muscle Wasting on Outcomes of Patients in the Surgical Intensive Care Unit
Ultrasound Assessment of Muscle to Quantify Frailty.
Status: Enrolling
Updated:  3/16/2016
643
mi
from 43215
Boston, MA
Effects of Frailty, Sarcopenia and Muscle Wasting on Outcomes of Patients in the Surgical Intensive Care Unit
Ultrasound Assessment of Muscle to Quantify Frailty.
Status: Enrolling
Updated: 3/16/2016
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion
Evaluation of a Neck Strengthening Program as a Potential Intervention to Reduce the Risk of Sport-related Concussion
Status: Enrolling
Updated:  3/16/2016
164
mi
from 43215
Ann Arbor, MI
Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion
Evaluation of a Neck Strengthening Program as a Potential Intervention to Reduce the Risk of Sport-related Concussion
Status: Enrolling
Updated: 3/16/2016
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Pre-oxygenation and Measures of Gas Exchanges During Seizures in the Epilepsy Monitoring Unit
Effects of Pre-oxygenation on Indicators of Gas Exchange and Autonomic Function During Seizures in the Epilepsy Unit
Status: Enrolling
Updated:  3/16/2016
478
mi
from 43215
New York, NY
Pre-oxygenation and Measures of Gas Exchanges During Seizures in the Epilepsy Monitoring Unit
Effects of Pre-oxygenation on Indicators of Gas Exchange and Autonomic Function During Seizures in the Epilepsy Unit
Status: Enrolling
Updated: 3/16/2016
NYU Langone Medical Center
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Registry for Study of Coils in Intracranial Aneurysms
Gaining Efficacy Long Term: Hydrosoft, an Emerging, New, Embolic Coil (Gel-the-nec)
Status: Enrolling
Updated:  3/17/2016
559
mi
from 43215
Rochester, MN
Registry for Study of Coils in Intracranial Aneurysms
Gaining Efficacy Long Term: Hydrosoft, an Emerging, New, Embolic Coil (Gel-the-nec)
Status: Enrolling
Updated: 3/17/2016
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients
A Single-center Prospective Measurement of Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients.
Status: Enrolling
Updated:  3/17/2016
823
mi
from 43215
Tampa, FL
Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients
A Single-center Prospective Measurement of Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients.
Status: Enrolling
Updated: 3/17/2016
USF Carol and Frank Morsani Center for Advanced Healthcare
823
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Neuronal and Glial Biomarkers in Stroke
Neuronal and Glial Biomarkers in Stroke
Status: Enrolling
Updated:  3/17/2016
714
mi
from 43215
Gainesville, FL
Neuronal and Glial Biomarkers in Stroke
Neuronal and Glial Biomarkers in Stroke
Status: Enrolling
Updated: 3/17/2016
University of Florida
714
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Assistive Device Training in Multiple Sclerosis
Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis
Status: Enrolling
Updated:  3/17/2016
2027
mi
from 43215
Portland, OR
Assistive Device Training in Multiple Sclerosis
Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis
Status: Enrolling
Updated: 3/17/2016
VA Portland Health Care System
2027
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
Status: Enrolling
Updated:  3/18/2016
481
mi
from 43215
New York, NY
Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
Status: Enrolling
Updated: 3/18/2016
Mount Sinai School of Medicine
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated:  3/18/2016
524
mi
from 43215
Stony Brook, NY
Treatment of Severe Childhood Aggression (The TOSCA Study)
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
State Univ of New York at Stony Brook
524
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated:  3/18/2016
129
mi
from 43215
Cleveland, OH
Treatment of Severe Childhood Aggression (The TOSCA Study)
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Case Western Reserve Univ
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated:  3/18/2016
2
mi
from 43215
Columbus, OH
Treatment of Severe Childhood Aggression (The TOSCA Study)
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
Ohio State University Nisonger Center
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Treatment of Severe Childhood Aggression (The TOSCA Study)
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated:  3/18/2016
164
mi
from 43215
Pittsburgh, PA
Treatment of Severe Childhood Aggression (The TOSCA Study)
Stimulant and Risperidone in Children With Severe Physical Aggression
Status: Enrolling
Updated: 3/18/2016
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Status: Enrolling
Updated:  3/18/2016
274
mi
from 43215
Chicago, IL
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Transcranial Direct Current Stimulation and Aphasia Language Therapy
Status: Enrolling
Updated: 3/18/2016
Center for Aphasia Research & Treatment, Rehabilitation Institute of Chicago
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated:  3/18/2016
1982
mi
from 43215
Los Angeles, CA
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated: 3/18/2016
University of California at Los Angeles
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated:  3/18/2016
822
mi
from 43215
Tampa, FL
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated: 3/18/2016
University of South Florida
822
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated:  3/18/2016
416
mi
from 43215
Philadelphia, PA
Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
Safety and Efficacy Study of EPI-743 on Visual Function in Patients With Friedreich's Ataxia
Status: Enrolling
Updated: 3/18/2016
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated:  3/18/2016
862
mi
from 43215
Bradenton, FL
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Florida Clinical Research Center, LLC
862
mi
from 43215
Bradenton, FL
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated:  3/18/2016
788
mi
from 43215
Maitland, FL
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Florida Clinical Research Center LLC
788
mi
from 43215
Maitland, FL
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated:  3/18/2016
997
mi
from 43215
South Miami, FL
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Miami Research Associates
997
mi
from 43215
South Miami, FL
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated:  3/18/2016
1762
mi
from 43215
Las Vegas, NV
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Center for Psychiatry and Behavioral Medicine, Inc.
1762
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated:  3/18/2016
352
mi
from 43215
Durham, NC
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated:  3/18/2016
996
mi
from 43215
Houston, TX
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Bayou City Research, Ltd.
996
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated:  3/18/2016
991
mi
from 43215
Houston, TX
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Westex Clinical Investigations
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Novel Stimulation Patterns for the Treatment of Dystonia
Novel Stimulation Patterns and Personalized Deep Brain Stimulation for the Treatment of Dystonia
Status: Enrolling
Updated:  3/18/2016
716
mi
from 43215
Gainesville, FL
Novel Stimulation Patterns for the Treatment of Dystonia
Novel Stimulation Patterns and Personalized Deep Brain Stimulation for the Treatment of Dystonia
Status: Enrolling
Updated: 3/18/2016
Center for Movement Disorders and Neurorestoration
716
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Safety Study for Adolescents With Concussion
Evaluation of the Safety of Exercise Testing With Acutely Concussed Adolescent Athletes
Status: Enrolling
Updated:  3/18/2016
299
mi
from 43215
Buffalo, NY
Safety Study for Adolescents With Concussion
Evaluation of the Safety of Exercise Testing With Acutely Concussed Adolescent Athletes
Status: Enrolling
Updated: 3/18/2016
University at Buffalo
299
mi
from 43215
Buffalo, NY
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated:  3/21/2016
1639
mi
from 43215
Tucson, AZ
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
University of Arizona
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated:  3/21/2016
1972
mi
from 43215
Los Angeles, CA
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
Cedars-Sinai Medical Center
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated:  3/21/2016
1982
mi
from 43215
Los Angeles, CA
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
Ronald Reagan UCLA Medical Center
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated:  3/21/2016
277
mi
from 43215
Chicago, IL
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated:  3/21/2016
461
mi
from 43215
Iowa City, IA
MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Status: Enrolling
Updated: 3/21/2016
University of Iowa
461
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials